NFE2L2 and non-small cell lung carcinoma: Kras-dependent upregulation of Nrf2 target genes, seen in non-small cell lung cancer (NSCLC) by Tao, et al. [111], further indicates an oncogene-dependent induction of Nrf2 activity.